TGF/BMP signalling and Pulmonary Hypertension
Dr Mark Toshner answers the question; will Sotatercept be the first drug to treat the common forms of pulmonary hypertension?
Tuesday 2 June, 7pm - 8pm
This insightful and educational session is part of the RESP (Respiratory Expert Speaker and Patient) webinar series, proudly presented by Respiratory Futures, INSPIRE and Asthma + Lung UK.
This webinar features expert speaker Dr Mark Toshner.
This session will cover
- Management of Pulmonary Hypertension for the non-specialist
- Novel treatment options
- Expert patient insights
Meet the speaker
Mark leads a translational research programme focused on therapy development in cardiorespiratory disease leveraging novel adaptive methods and technology enabled clinical trials. He is the Director of the VPD HLRI Clinical Research Facility in Cambridge and the Director of the UniPHy national trials network in pulmonary hypertension.
Clinical tags:
Recently added
-
Episode 23 | Improving treatment and management of rare diseases
In this episode, we sit down with Professor Kev Dhaliwal, NHS respiratory consultant and lead at...
-
London and KSS Respiratory Women’s Network
This network was launched by four London-based respiratory trainees. It aims to inspire, support and...
-
Episode 22 | Latest Developments in Chronic Cough
Chronic Cough Chronic Cough: a cough that lasts eight weeks or longer in adults or four weeks...
-
Department of Health & Social Care Pandemic Preparedness Strategy
The Department of Health and Social Care has written a policy paper setting out how the UK intends...
-
Episode 21 | Supporting Women in Respiratory
An International Women’s Day special Women in Respiratory is a community-led initiative here...